Silo Pharma Stock Today

SILO Stock  USD 1.90  0.07  3.55%   


13 of 100


Odds Of Distress

Over 65

Quite High
Silo Pharma is selling at 1.90 as of the 16th of April 2024; that is -3.55 percent down since the beginning of the trading day. The stock's open price was 1.97. Silo Pharma has more than 65 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Silo Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of April 2023 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
13th of May 2014
Health Care
Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. Silo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 2.84 M outstanding shares of which 61.39 K shares are at this time shorted by private and institutional investors with about 0.46 trading days to cover. More on Silo Pharma

Moving against Silo Stock

  0.83BIIB Biogen Inc Financial Report 23rd of April 2024 PairCorr
  0.77VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr
  0.71JNJ Johnson Johnson Earnings Call TodayPairCorr
  0.7AMGN Amgen Inc Financial Report 25th of April 2024 PairCorr
  0.46ABVC ABVC BiopharmaPairCorr

Silo Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Silo Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Silo Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President ChairmanEric Weisblum
Thematic IdeaApparel (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Jakarta Stock Exchange, Apparel, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Silo Pharma report their recommendations after researching Silo Pharma's financial statements, talking to executives and customers, or listening in on Silo Pharma's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Silo Pharma. The Silo consensus assessment is calculated by taking the average forecast from all of the analysts covering Silo Pharma.
Financial Strength
Based on the key measurements obtained from Silo Pharma's financial statements, Silo Pharma is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Silo Pharma is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities814.4 K775.6 K
Sufficiently Up
Slightly volatile
Non Current Liabilities Total458.8 K793.7 K
Way Down
Slightly volatile
Total Assets8.1 M7.7 M
Sufficiently Up
Slightly volatile
Total Current Assets8.1 M7.7 M
Sufficiently Up
Slightly volatile
Silo Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Silo Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Silo Pharma's financial leverage. It provides some insight into what part of Silo Pharma's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Silo Pharma's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Silo Pharma deploys its capital and how much of that capital is borrowed.
Silo Pharma cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has a current ratio of 32.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Silo Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Silo Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Silo Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Silo to invest in growth at high rates of return. When we think about Silo Pharma's use of debt, we should always consider it together with cash and equity.

Total Cash From Financing Activities

Silo Pharma (SILO) is traded on NASDAQ Exchange in USA. It is located in 560 Sylvan Avenue, Englewood Cliffs, NJ, United States, 07632 and employs 3 people. Silo Pharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Silo Pharma's market, we take the total number of its shares issued and multiply it by Silo Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Silo Pharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.84 M outstanding shares of which 61.39 K shares are at this time shorted by private and institutional investors with about 0.46 trading days to cover. Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Silo Pharma Probability Of Bankruptcy
Ownership Allocation
Silo Pharma has 6.35 % of its outstanding shares held by insiders and 5.6 % owned by institutional holders.
Check Silo Ownership Details

Silo Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Silo Pharma jumping above the current price in 90 days from now is about 11.51%. The Silo Pharma probability density function shows the probability of Silo Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Silo Pharma has a beta of -0.018. This usually implies as returns on the benchmark increase, returns on holding Silo Pharma are expected to decrease at a much lower rate. During a bear market, however, Silo Pharma is likely to outperform the market. Additionally, silo Pharma has an alpha of 0.3995, implying that it can generate a 0.4 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 1.9HorizonTargetOdds Above 1.9
88.43%90 days
Based on a normal probability distribution, the odds of Silo Pharma to move above the current price in 90 days from now is about 11.51 (This Silo Pharma probability density function shows the probability of Silo Stock to fall within a particular range of prices over 90 days) .

Silo Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Silo Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Silo Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Silo Pharma's value.
InstituionRecorded OnShares
Financial Advocates Investment Management2023-12-31
62.8 K
Ubs Group Ag2023-12-31
32.8 K
Vanguard Group Inc2023-12-31
16.3 K
Geode Capital Management, Llc2023-12-31
16.2 K
Two Sigma Securities, Llc2023-12-31
12.8 K
State Street Corporation2023-12-31
12.5 K
Tower Research Capital Llc2023-12-31
Westside Investment Management, Inc.2023-12-31
Fwl Investment Management, Llc2023-12-31
Wells Fargo & Co2023-12-31
Jpmorgan Chase & Co2023-09-30
View Silo Pharma Diagnostics

Silo Pharma Historical Income Statement

Silo Pharma Income Statement is one of the three primary financial statements used for reporting Silo's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Silo Pharma revenue and expense. Silo Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Silo Pharma's Net Interest Income is very stable compared to the past year. As of the 16th of April 2024, Interest Income is likely to grow to about 379.1 K, though Operating Income is likely to grow to (3.7 M). View More Fundamentals

Silo Stock Against Markets

Picking the right benchmark for Silo Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Silo Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Silo Pharma is critical whether you are bullish or bearish towards Silo Pharma at a given time. Please also check how Silo Pharma's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Silo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now


Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

How to buy Silo Stock?

Before investing in Silo Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Silo Pharma. To buy Silo Pharma stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Silo Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Silo Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Silo Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Silo Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Silo Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Silo Stock please use our How to Invest in Silo Pharma guide.

Already Invested in Silo Pharma?

The danger of trading Silo Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Silo Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Silo Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Silo Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Silo Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silo Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silo Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silo Pharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silo Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Silo Stock, please use our How to Invest in Silo Pharma guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Silo Stock analysis

When running Silo Pharma's price analysis, check to measure Silo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silo Pharma is operating at the current time. Most of Silo Pharma's value examination focuses on studying past and present price action to predict the probability of Silo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silo Pharma's price. Additionally, you may evaluate how the addition of Silo Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Silo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silo Pharma. If investors know Silo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Return On Assets
Return On Equity
The market value of Silo Pharma is measured differently than its book value, which is the value of Silo that is recorded on the company's balance sheet. Investors also form their own opinion of Silo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Silo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silo Pharma's market value can be influenced by many factors that don't directly affect Silo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silo Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.